Two Sigma Investments, LP Sensei Biotherapeutics, Inc. Call Options Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SNSE
# of Institutions
26Shares Held
2.4MCall Options Held
0Put Options Held
0-
Ikarian Capital, LLC Dallas, TX650KShares$298,9820.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$273,4480.0% of portfolio
-
Catalio Capital Management, LP New York, NY294KShares$135,4120.03% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$79,4870.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$72,1280.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $14.1M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...